Omega-3-acid ethyl esters(Trygg Pharma AS)

AUSTIN, Texas and TOKYO, Jan. 9, 2026 /PRNewswire/ -- According to DataM Intelligence, the global Algae Omega-3 Ingredients Market was valued at USD 850.5 million in 2024 and is projected to reach USD 1,471.3 million by 2032, expanding at a CAGR of 7.4% during the forecast period 2025–2032. This steady growth reflects a decisive shift in global nutrition and health strategies. As concerns around overfishing, sustainability, and purity intensify, algae-derived omega-3s are increasingly replacing traditional fish-oil sources across infant nutrition, dietary supplements, fortified foods, pharmaceuticals, and animal nutrition. By 2030, algae omega-3 ingredients will no longer be positioned as niche alternatives. They will be recognized as strategic, scalable, and environmentally resilient sources of DHA and EPA, aligned with long-term health, sustainability, and regulatory priorities. Why Algae-Based Omega-3 is Gaining Strategic Momentum The rise of algae omega-3 ingredients is underpinned by three structural forces reshaping global nutrition markets. Sustainability has become non-negotiable. Conventional fish-oil supply chains face volatility due to declining fish stocks, climate disruption, and regulatory scrutiny. Algae-based production bypasses marine harvesting entirely, offering consistent output with significantly lower environmental impact. Purity and traceability are increasingly critical. Algae-derived DHA and EPA are produced in controlled fermentation environments, minimizing contamination risks associated with heavy metals, microplastics, and ocean pollutants. This advantage is particularly important in infant nutrition and pharmaceutical applications. Consumer demand for plant-based and clean-label nutrition is accelerating. Vegan, vegetarian, and flexitarian consumers are actively seeking omega-3 sources aligned with ethical and dietary preferences, pushing brands to reformulate products using algae-based ingredients. As a result, algae omega-3 ingredients are transitioning from a premium substitute into a core component of next-generation nutrition portfolios. Request Executive Sample | Algae Omega-3 Ingredients Market Intelligence: Segmentation Analysis By Type Docosahexaenoic Acid (DHA) dominates the algae omega-3 ingredients market, accounting for approximately 62% of total market value in 2024, equivalent to around USD 527 million. DHA is essential for brain development, vision health, and cognitive function, making it indispensable in infant formula, prenatal supplements, and functional foods. Eicosapentaenoic Acid (EPA) represents the remaining 38%, or approximately USD 323.5 million. EPA is increasingly used for cardiovascular health, inflammation management, and therapeutic applications. While historically more associated with fish oil, EPA from algae is gaining traction as production efficiency improves. According to DataM Intelligence analysis, DHA will remain the primary revenue driver through 2032, while EPA will record faster relative growth as pharmaceutical and clinical applications expand. By Application Infant nutrition represents the largest application segment, accounting for approximately 34% of global market value, or USD 289 million in 2024. Regulatory mandates for DHA inclusion in infant formula across multiple regions have firmly established algae-based DHA as the gold standard due to its purity and safety profile. Dietary supplements account for around 27%, or USD 230 million. This segment is driven by adult consumers seeking heart, brain, and eye health benefits, particularly within plant-based and premium supplement categories. Fortified food and beverages represent approximately 18%, or USD 153 million, supported by growing incorporation of omega-3s into dairy alternatives, beverages, cereals, and functional snacks. Animal nutrition, including aquaculture and pet food, contributes around 13%, or USD 111 million. Algae omega-3s are increasingly used to enrich animal products while reducing reliance on fishmeal and fish oil. Pharmaceutical applications account for the remaining 8%, or roughly USD 67 million, reflecting use in prescription formulations and clinical nutrition. According to DataM Intelligence analysis, infant nutrition will remain the anchor application, while supplements and animal nutrition will deliver strong incremental growth through 2032. By Form Type Triglyceride forms dominate the market with approximately 46% share, equivalent to USD 391 million in 2024. Triglycerides offer high bioavailability and stability, making them preferred for dietary supplements and infant nutrition. Ethyl ester forms account for around 32%, or USD 272 million, commonly used in concentrated formulations and pharmaceutical-grade applications. Phospholipids represent approximately 22%, or USD 187 million. This segment is gaining importance due to superior absorption and growing interest in cognitive and clinical nutrition. According to DataM Intelligence analysis, phospholipid-based omega-3s will experience above-average growth, particularly in medical and premium nutrition products. Request Customized Intelligence Aligned to Your Business Strategy: Regional Analysis United States The United States represents the largest single market, accounting for approximately 38% of global revenue, or around USD 323 million in 2024. Key drivers include: High consumption of dietary supplements Strong infant formula demand Rapid adoption of plant-based nutrition Robust innovation across functional foods By 2032, the U.S. algae omega-3 ingredients market is projected to exceed USD 560 million, maintaining global leadership. Europe Europe accounts for approximately 30% of global market value, supported by strict sustainability regulations, high infant nutrition standards, and strong demand for clean-label ingredients. Asia-Pacific Asia-Pacific represents the fastest-growing regional market, driven by expanding infant formula consumption, rising health awareness, and growing domestic production capabilities. Competitive Landscape The Algae Omega-3 Ingredients Market is being reinforced by the combined efforts of Koninklijke DSM N.V., ADM, Corbion, BASF, Polaris S.A., and Neptune Wellness Solutions Inc., and others . Together, these companies are driving the transition toward sustainable, plant-based omega-3 sources that address supply chain volatility associated with fish-derived alternatives. Their investments in algae cultivation, fermentation technologies, and high-purity extraction support consistent quality and scalable production. As demand rises across dietary supplements, fortified foods, and infant nutrition, their participation strengthens credibility and long-term growth within the Algae Omega-3 Ingredients Market. The competitive advantage of the Algae Omega-3 Ingredients Market is further shaped by how these companies' strengths align across innovation, scale, and market access. Global leaders contribute robust R&D capabilities, regulatory expertise, and broad distribution networks, while specialized players enhance formulation flexibility and targeted application development. This complementary dynamic accelerates product adoption across health-focused consumer segments and supports rapid commercialization of next-generation omega-3 solutions. Collectively, they create a resilient and innovation-driven ecosystem that advances differentiation and sustained momentum in the Algae Omega-3 Ingredients Market. What will define the Market by 2031–2032 By 2031, the algae omega-3 ingredients market is expected to approach USD 1.4 billion, driven by: Expansion of infant formula regulations Rising adoption of vegan and plant-based supplements Increased use in animal nutrition and aquaculture Improved production efficiency and cost competitiveness According to DataM Intelligence analysis: DHA will remain the dominant omega-3 type Infant nutrition will continue as the largest application Triglyceride forms will lead to volume demand The U.S. will retain the largest regional share By 2032, algae omega-3 ingredients will be firmly embedded in global nutrition, pharmaceutical, and sustainable food systems. Purchase Corporate License | Algae Omega-3 Ingredients Market Intelligence: Executive Takeaway For nutrition, pharmaceutical, and ingredient-industry leaders, algae omega-3 ingredients represent a strategic intersection of health science, sustainability, and long-term supply security. Scale fermentation-based omega-3 production efficiently Align products with regulatory and clean-label requirements Expand applications beyond supplements into food, feed, and pharma Communicate sustainability and purity advantages clearly As global nutrition priorities evolve, algae-derived omega-3s will play a defining role in shaping the future of essential fatty acid supply over the next decade. Related Report: Omega-3 Supplements Market to Almost Double to USD 17.08 Billion by 2032 with a 9.59% CAGR - DataM Intelligence. Algae Omega-3 Market to Grow from USD 1.2 Billion in 2023 to USD 1.7 Billion by 2031 at a 4.5% CAGR - DataM Intelligence Report Highlights Surge in Sustainable Nutrition. Omega-3 Concentrates Market to Grow from USD 3.02 Billion in 2024 to USD 5.11 Billion by 2032 at a 6.8% CAGR - DataM Intelligence. Microencapsulated Omega-3 Powders Market to Surge from USD 16.6 Billion in 2022 to USD 30.5 Billion by 2030 at a 7.9% CAGR - DataM Intelligence. About DataM Intelligence DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations. To find out more, visit or follow us on Twitter, LinkedIn, and Facebook. Contact: Sai Kiran DataM Intelligence 4market Research LLP Ground floor, DSL Abacus IT Park, Industrial Development Area Uppal, Hyderabad, Telangana 500039 USA: +1 877-441-4866 Email: [email protected] Logo: SOURCE DataM Intelligence 4 Market Research LLP 21% more press release views with Request a Demo